# Clinical, neuropsychological, and neuroimaging profiles of patients with treatment-resistant depression receiving intravenous ketamine treatment: an exploratory multimodal case series - URL: https://alisanburak.com/en/wcp-2026-posterler/ev0809 - Language: en - Last updated: not specified - Page title: Clinical, neuropsychological, and neuroimaging profiles of patients with treatment-resistant depression receiving intravenous ketamine treatment: an exploratory multimodal case series | WCP 2026 Summary > A combined mood–executive phenotype characterized by co-occurring clinical severity, executive dysfunction, and disrupted connectivity in large-scale brain net… This page was translated automatically from Turkish. [Read the original](https://alisanburak.com/wcp-2026-posterler/ev0809) This page is an AI-assisted Turkish summary of the study presented at the 26th World Congress of Psychiatry. The study belongs to the presenting authors; please refer to the original source when citing it. EV0809 E-PosterNeuroscience and ImagingRetrospective observational case series # Clinical, neuropsychological, and neuroimaging profiles of patients with treatment-resistant depression receiving intravenous ketamine treatment: an exploratory multimodal case series CLINICAL, NEUROPSYCHOLOGICAL, AND NEUROIMAGING PROFILES OF TREATMENT-RESISTANT DEPRESSION IN PATIENTS TREATED WITH INTRAVENOUS KETAMINE: AN EXPLORATORY MULTIMODAL CASE SERIES Presenter: Micaela Dines Country: Argentina A combined mood–executive phenotype characterized by co-occurring clinical severity, executive dysfunction, and disrupted connectivity in large-scale brain networks was identified in patients with treatment-resistant depression who were candidates for intravenous ketamine. The aim was to describe the clinical, neuropsychological, and neuroimaging profiles of patients with treatment-resistant depression (TRD) before intravenous (IV) ketamine treatment. This retrospective, observational, naturalistic study assessed 8 patients with TRD (4 women, 4 men; mean age 38.5 +/- 10.3 years) at baseline. Clinical assessment used the BDI-II and MADRS; the neuropsychological battery examined executive functions, attention, and episodic memory; resting-state fMRI assessed functional connectivity of the DMN, SN, FP/CEN, and subgenual anterior cingulate cortex (sgACC), while diffusion tensor imaging (DTI) assessed white matter integrity and fractional anisotropy. Findings revealed decoupling between the FP/CEN and SN in 87.5% of patients, hypoconnectivity of the sgACC with prefrontal and salience regions in 75%, DMN fragmentation in 62.5%, and white matter microstructural alterations in 62.5%; the most affected tracts were the arcuate fasciculus, external capsule, and superior longitudinal fasciculus III. Clinical findings included severe depression (BDI-II and MADRS), persistent anhedonia and rumination, substantial functional disability, and moderate impairment in executive functions and attention, with relative preservation of episodic memory. Overall, the findings support a transdiagnostic, multiple-network model of TRD; integrated multimodal assessment may improve patient selection for ketamine, and sgACC, SN, FP/CEN, and DMN markers are proposed as candidates for treatment response prediction models. The authors emphasize the need for longitudinal studies with larger samples. [View the original poster](https://cslide.ctimeetingtech.com/wcp26/attendee/eposter/file/547) How to cite this study APA 7: Dines, M., Majul, V., Bamondez, P., Bulacia, A., & Vazquez, G. (2026, September 23-26). Clinical, neuropsychological, and neuroimaging profiles of treatment-resistant depression in patients treated with intravenous ketamine: an exploratory multimodal case series [E-poster]. 26th WPA World Congress of Psychiatry (WCP 2026), Stockholm, Sweden. https://cslide.ctimeetingtech.com/wcp26/attendee/eposter/file/547 Vancouver: Dines M, Majul V, Bamondez P, Bulacia A, Vazquez G. Clinical, neuropsychological, and neuroimaging profiles of treatment-resistant depression in patients treated with intravenous ketamine: an exploratory multimodal case series [e-poster]. 26th WPA World Congress of Psychiatry (WCP 2026); 2026 Sep 23-26; Stockholm, Sweden. Available from: https://cslide.ctimeetingtech.com/wcp26/attendee/eposter/file/547 Author names and title formatting were generated automatically from the congress system; please check them against the original poster before use. ## On the same topic - [5-HTTLPR ve MAOA genotiplerinin Iowa kumar görevinde risk altında karar verme üzerindeki farklı duyarlılık etkileri](https://alisanburak.com/en/wcp-2026-posterler/ev0042) - [Duygusal düzensizliği olan erişkin DEHB hastalarında merkezi noradrenalin taşıyıcısı erişilebilirliğinin [11C]MRB PET/MRI ile in vivo görüntülenmesi ve nicelenmesi](https://alisanburak.com/en/wcp-2026-posterler/ev0065) - [Erişkin DEHB'de sapmış beyin kritikliği: uzun erimli zamansal korelasyonlar ve görüntüleme transkriptomiğinden çıkarımlar](https://alisanburak.com/en/wcp-2026-posterler/ev0067) - [Anksiyete biyobelirteci olarak fibroblast büyüme faktörü 2: tehdide yönelik dikkat yanlılığıyla ilişkileri](https://alisanburak.com/en/wcp-2026-posterler/ev0120) - [Trajedi paradoksu: hüzünlü müzikle olumlu duygudurum düzenlenmesinin psikolojik ve nörobiyolojik mekanizmaları](https://alisanburak.com/en/wcp-2026-posterler/ev0134) [All WCP 2026 summaries](https://alisanburak.com/en/wcp-2026-posterler) --- Kaynak / Source: https://alisanburak.com/en/wcp-2026-posterler/ev0809 İletişim / Contact: Bağdat Caddesi, Veli Güneysu Apt. No:453 K:4 D:9, Suadiye / Kadıköy, İstanbul · +90 532 642 95 25 · info@alisanburak.com · https://alisanburak.com/bagdat-caddesi-psikoterapi-iletisim